Elevance Health (ELV) Stock Price & Analysis
Score
AI Analysis
SnapshotElevance Health doesn’t screen as a clean setup today — Stocklytics 39/100 leaves more to prove. Under the hood: P/E 18.5, plus revenue compounding ~8% annually over recent years.
Price History
Price: —
Fair value: —
—
P/E (TTM): —
Net Income (TTM): —
Score: —
—
Score Breakdown
Market percentile scores loading…
Value
Growth
Quality
Financial Summary
Elevance Health Inc. (ELV) last printed $429.69. Equity value is $92.84B. Trailing earnings multiple 18.07. The revenue row is reported history. Targets and ratings are on the forecast page.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| $84.98B | $90.04B | $92.11B | $104.21B | $121.87B | $138.64B | $156.59B | $171.34B | $176.81B | $199.12B |
About
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.